EV/EBITDA
-3.00
NaN%
Thu, 06 Feb 2025 21:00:00 GMT
Summary
- As of February 22, 2025, RVNC EV/EBITDA is -3.00
- Over the past year, RVNC EV/EBITDA has dropped by -0.15 (-5.26%).
- RVNC EV/EBITDA is now -47.78% below its all-time high of -2.03.
Performance
RVNC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RVNC EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| 1 m1 month | +0.3% | -0.3% | -0.5% |
| 3 m3 months | +4.2% | -4.1% | -8.3% |
| 6 m6 months | +25.6% | -26.4% | -44.6% |
| ytdytd | -8.3% | +8.3% | +19.3% |
| 1 y1 year | -5.3% | -1.2% | -32.4% |
| 5 y5 years | +67.4% | -44.0% | -86.9% |
RVNC EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -3.01 | +0.3% | |
| 3 m | 3-month | -2.75 | -9.1% | -3.20 | +6.3% |
| 6 m | 6-month | -2.75 | -9.1% | -4.03 | +25.6% |
| 1 y | 1-year | -2.03 | -47.8% | -4.04 | +25.7% |
| 3 y | 3-year | -2.03 | -47.8% | -12.34 | +75.7% |
| 5 y | 5-year | -2.03 | -47.8% | -12.34 | +75.7% |
| alltime | all time | -2.03 | -47.8% | -20.50 | +85.4% |
Revance Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.00(+8.3%) |
| 2024 | -2.77(-29.7%) |
| 2023 | -3.94(-42.6%) |
| 2022 | -6.87(+26.8%) |
| 2021 | -5.42(-23.6%) |
| 2020 | -7.09(+56.9%) |
| Date | Value |
|---|---|
| 2019 | -4.52(-7.2%) |
| 2018 | -4.87(-43.6%) |
| 2017 | -8.63(+39.9%) |
| 2016 | -6.17(-43.9%) |
| 2015 | -11.00(+134.5%) |
| 2014 | -4.69 |
FAQ
- What is Revance Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Revance Therapeutics?
- What is RVNC EV/EBITDA year-to-date change?
- What is Revance Therapeutics EV/EBITDA year-on-year change?
What is Revance Therapeutics EV/EBITDA?
The current EV/EBITDA of RVNC is -3.00
What is the all time high EV/EBITDA for Revance Therapeutics?
Revance Therapeutics all-time high EV/EBITDA is -2.03
What is RVNC EV/EBITDA year-to-date change?
Revance Therapeutics EV/EBITDA has changed by -0.23 (-8.30%) since the beginning of the year
What is Revance Therapeutics EV/EBITDA year-on-year change?
Over the past year, RVNC EV/EBITDA has changed by -0.15 (-5.26%)